JCI Disease classification, diagnostic challenges, and evolving clinical trial design in MASLD

(Punjab News) Amritsar. Livasa Hospital, Amritsar organized an important press conference on MASLD (Metabolic dysfunction-related steatotic liver disease): a growing health challenge. The aim of the event was to increase public awareness about MASLD, encourage early detection of the disease, and highlight the need for adopting a multidisciplinary approach in its treatment. The occasion was attended by several senior experts from the field of gas…

JCI Disease classification, diagnostic challenges, and evolving clinical trial design in MASLD

Metabolic dysfunction–associated steatotic liver disease (MASLD) diagnosis and management have evolved rapidly alongside the increasing prevalence of obesity and related complications. Hepatology has expanded its focus beyond late-stage cirrhosis and portal hypertension to earlier, complex MASLD cases in younger patients, necessitating closer collaboration with endocrinology. The renaming of nonalcoholic fatty liver disease (NAFLD) to MASLD refl…